HomeAVDL • NASDAQ
add
Avadel Pharmaceuticals PLC
Previous close
$9.60
Day range
$9.31 - $9.79
Year range
$6.38 - $17.30
Market cap
914.74M USD
Avg Volume
1.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.00033%
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 52.51M | 93.21% |
Operating expense | 49.94M | -3.40% |
Net income | -4.92M | 82.01% |
Net profit margin | -9.37 | 90.69% |
Earnings per share | -0.05 | 83.33% |
EBITDA | -2.18M | 91.46% |
Effective tax rate | -1.61% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 66.48M | -25.12% |
Total assets | 167.95M | 0.03% |
Total liabilities | 93.88M | 4.88% |
Total equity | 74.07M | — |
Shares outstanding | 96.74M | — |
Price to book | 12.47 | — |
Return on assets | -4.52% | — |
Return on capital | -6.61% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -4.92M | 82.01% |
Cash from operations | -8.23M | 72.29% |
Cash from investing | 12.32M | -42.41% |
Cash from financing | 690.00K | -94.77% |
Net change in cash | 5.00M | 8.04% |
Free cash flow | -8.71M | 55.25% |
About
Avadel Pharmaceuticals, is an Irish specialty pharmaceutical company that focuses on sleep disorder medicines. Avadel markets products in the hospital and primary care spaces. The company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. Wikipedia
Founded
1990
Website
Employees
188